Sökning: WFRF:(Lange Tanja) > Prognostic Impact o...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 09600naa a2200937 4500 | |
001 | oai:DiVA.org:uu-507040 | |
003 | SwePub | |
008 | 230704s2023 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:152841587 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5070402 URI |
024 | 7 | a https://doi.org/10.1016/j.jaip.2022.10.0512 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1528415872 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Lübke, Johannesu Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.4 aut |
245 | 1 0 | a Prognostic Impact of Organomegaly in Mastocytosis :b An Analysis of the European Competence Network on Mastocytosis |
264 | 1 | b Elsevier,c 2023 |
338 | a print2 rdacarrier | |
520 | a BACKGROUND: Organomegaly, including splenomegaly, hepatomegaly, and/or lymphadenopathy, are important diagnostic and prognostic features in patients with cutaneous mastocytosis (CM) or systemic mastocytosis (SM).OBJECTIVES: To investigate the prevalence and prognostic impact of 1 or more organomegalies on clinical course and survival in patients with CM/SM.METHODS: Therefore, 3155 patients with CM (n = 1002 [32%]) or SM (n = 2153 [68%]) enrolled within the registry of the European Competence Network on Mastocytosis were analyzed. RESULTS: Overall survival (OS) was adversely affected by the number of organomegalies (OS: #0 vs #1 hazard ratio [HR], 4.9; 95% CI, 3.4-7.1, P < .001; #1 vs #2 HR, 2.1, 95% CI, 1.4-3.1, P < .001; #2 vs #3 HR, 1.7, 95% CI, 1.2-2.5, P = .004). Lymphadenopathy was frequently detected in patients with smoldering SM (SSM, 18 of 60 [30%]) or advanced SM (AdvSM, 137 of 344 [40%]). Its presence confered an inferior outcome in patients with AdvSM compared with patients with AdvSM without lymphadenopathy (median OS, 3.8 vs 2.6 years; HR, 1.6; 95% CI, 1.2-2.2; P = .003). OS was not different between patients having organomegaly with either ISM or SSM (median, 25.5 years vs not reached; P = .435). At time of disease progression, a new occurrence of any organomegaly was observed in 17 of 40 (43%) patients with ISM, 4 of 10 (40%) patients with SSM, and 33 of 86 (38%) patients with AdvSM, respectively.CONCLUSIONS: Organomegalies including lymphadenopathy are often found in SSM and AdvSM. ISM with organomegaly has a similar course and prognosis compared with SSM. The number of organomegalies is adversely associated with OS. A new occurrence of organomegaly in all variants of SM may indicate disease progression. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng |
653 | a Mastocytosis | |
653 | a Systemic mastocytosis | |
653 | a Organomegaly | |
653 | a Splenomegaly | |
653 | a Hepatomegaly | |
653 | a Lymphadenopathy | |
700 | 1 | a Schwaab, Julianau Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.4 aut |
700 | 1 | a Christen, Deborahu Univ Hosp RWTH Aachen, Dept Oncol Haematol Haemostaseol & Stem Cell Tran, Aachen, Germany.4 aut |
700 | 1 | a Elberink, Hanneke Oudeu Univ Groningen, Univ Med Ctr Groningen, Dept Allergol, Groningen, Netherlands.4 aut |
700 | 1 | a Span, Bartu Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands.4 aut |
700 | 1 | a Niedoszytko, Mareku Med Univ Gdansk, Dept Allergol, Gdansk, Poland.4 aut |
700 | 1 | a Gorska, Aleksandrau Med Univ Gdansk, Dept Allergol, Gdansk, Poland.4 aut |
700 | 1 | a Lange, Magdalenau Med Univ Gdansk, Dept Dermatol, Gdansk, Poland.4 aut |
700 | 1 | a Gleixner, Karoline V.u Med Univ Vienna, Dept Int Med 1, Div Hematol & Hemostaseol, Vienna, Austria.;Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria.4 aut |
700 | 1 | a Hadzijusufovic, Emiru Med Univ Vienna, Dept Int Med 1, Div Hematol & Hemostaseol, Vienna, Austria.;Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria.;Univ Vet Med, Univ Clin Small Anim, Dept Univ Clin Compan Anim & Horses, Internal Med Small Anim, Vienna, Austria.4 aut |
700 | 1 | a Solomianyi, Oleksiiu Johannes Kepler Univ Linz, Univ Clin Hematol & Oncol, Kepler Univ Hosp, Linz, Austria.4 aut |
700 | 1 | a Angelova-Fischer, Irenau Johannes Kepler Univ Linz, Kepler Univ Hosp, Allergy Ctr, Dept Dermatol & Venereol, Linz, Austria.4 aut |
700 | 1 | a Zanotti, Robertau Verona Univ Hosp, Dept Med, Sect Hematol, Verona, Italy.4 aut |
700 | 1 | a Bonifacio, Massimilianou Verona Univ Hosp, Dept Med, Sect Hematol, Verona, Italy.4 aut |
700 | 1 | a Bonadonna, Patriziau Verona Univ Hosp, Allergy Unit, Verona, Italy.4 aut |
700 | 1 | a Shoumariyeh, Khalidu Univ Freiburg, Fac Med, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.;German Canc Consortium DKTK Partner Site Freiburg, Freiburg, Germany.4 aut |
700 | 1 | a von Bubnoff, Nikolasu Univ Freiburg, Fac Med, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.;German Canc Consortium DKTK Partner Site Freiburg, Freiburg, Germany.;Univ Schleswig Holstein, Med Ctr, Dept Hematol & Oncol, Campus Lubeck, Lubeck, Germany.4 aut |
700 | 1 | a Mueller, Sabineu Univ Freiburg, Fac Med, Med Ctr, Dept Dermatol, Freiburg, Germany.4 aut |
700 | 1 | a Perkins, Ceceliau Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA.4 aut |
700 | 1 | a Elena, Chiarau Univ Pavia, Dept Mol Med, Pavia, Italy.;Univ Pavia, Dept Hematol Oncol, Pavia, Italy.;Fdn IRCCS Policlin San Matteo, Pavia, Italy.4 aut |
700 | 1 | a Malcovati, Lucau Univ Pavia, Dept Mol Med, Pavia, Italy.;Univ Pavia, Dept Hematol Oncol, Pavia, Italy.;Fdn IRCCS Policlin San Matteo, Pavia, Italy.4 aut |
700 | 1 | a Hägglund, Hansu Uppsala universitet,Hematologi,Uppsala Univ, Dept Med Sci, Div Hematol, Uppsala, Sweden.4 aut0 (Swepub:uu)hanha689 |
700 | 1 | a Mattsson, Mattiasu Uppsala universitet,Hematologi4 aut0 (Swepub:uu)matma431 |
700 | 1 | a Parente, Robertau Univ Salerno, Div Allergy & Clin Immunol, Salerno, Italy.4 aut |
700 | 1 | a Varkonyi, Juditu Semmelwe Univ, Dept Hematol, Budapest, Hungary.4 aut |
700 | 1 | a Fortina, Anna Belloniu Univ Padua, Dept Med, Pediat Dermatol Unit, Padua, Italy.4 aut |
700 | 1 | a Caroppo, Francescau Univ Padua, Dept Med, Pediat Dermatol Unit, Padua, Italy.4 aut |
700 | 1 | a Zink, Alexanderu Karolinska Institutet,Techn Univ Munchen, Fac Med, Dept Dermatol & Allergy Biederstein, Munich, Germany.4 aut |
700 | 1 | a Brockow, Knutu Techn Univ Munchen, Fac Med, Dept Dermatol & Allergy Biederstein, Munich, Germany.4 aut |
700 | 1 | a Breynaert, Christineu Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Allergy & Clin Immunol Res Grp, Leuven, Belgium.;Univ Hosp Leuven, MASTeL, Leuven, Belgium.4 aut |
700 | 1 | a Bullens, Dominiqueu Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Allergy & Clin Immunol Res Grp, Leuven, Belgium.;Univ Hosp Leuven, MASTeL, Leuven, Belgium.4 aut |
700 | 1 | a Yavuz, Akif Selimu Istanbul Univ, Istanbul Med Sch, Div Hematol, Istanbul, Turkiye.4 aut |
700 | 1 | a Doubek, Michaelu Univ Hosp & Fac Med, Brno, Czech Republic.4 aut |
700 | 1 | a Sabato, Vitou Univ Antwerp, Fac Med & Hlth Sci, Dept Immunol Allergol Rheumatol, Antwerp, Belgium.;Antwerp Univ Hosp, Antwerp, Belgium.4 aut |
700 | 1 | a Schug, Tanjau Univ Hosp Graz, Dept Dermatol & Venereol, Graz, Austria.4 aut |
700 | 1 | a Niederwieser, Dietgeru Univ Hosp Leipzig, Leipzig, Germany.4 aut |
700 | 1 | a Hartmann, Karinu Univ Basel, Dept Dermatol, Div Allergy, Basel, Switzerland.;Uni Hosp Basel, Dept Biomed, Basel, Switzerland.;Univ Basel, Basel, Switzerland.4 aut |
700 | 1 | a Triggiani, Massimou Univ Salerno, Div Allergy & Clin Immunol, Salerno, Italy.4 aut |
700 | 1 | a Gotlib, Jasonu Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA.4 aut |
700 | 1 | a Hermine, Olivieru Univ Paris 05, Hop Necker, AP HP, Imagine Inst,French Reference Ctr Mastocytosis CE, Paris, France.4 aut |
700 | 1 | a Arock, Michelu Hop La Pitie Salpetriere, Lab Hematol, Paris, France.4 aut |
700 | 1 | a Kluin-Nelemans, Hanneke C.u Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands.4 aut |
700 | 1 | a Panse, Jensu Univ Hosp RWTH Aachen, Dept Oncol Haematol Haemostaseol & Stem Cell Tran, Aachen, Germany.;Aachen Bonn Cologne Dusseldorf CIO ABCD, Ctr Integrated Oncol, Aachen, Germany.4 aut |
700 | 1 | a Sperr, Wolfgang R.u Med Univ Vienna, Dept Int Med 1, Div Hematol & Hemostaseol, Vienna, Austria.;Med Univ Vienna, Ludwig Boltzmann Inst Hematol & Oncol, Vienna, Austria.4 aut |
700 | 1 | a Valent, Peter4 aut |
700 | 1 | a Reiter, Andreasu Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.4 aut |
700 | 1 | a Jawhar, Mohamadu Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.4 aut |
710 | 2 | a Heidelberg Univ, Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany.b Univ Hosp RWTH Aachen, Dept Oncol Haematol Haemostaseol & Stem Cell Tran, Aachen, Germany.4 org |
773 | 0 | t Journal of Allergy and Clinical Immunologyd : Elsevierg 11:2, s. 581-590q 11:2<581-590x 2213-2198x 2213-2201 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-507040 |
856 | 4 8 | u https://doi.org/10.1016/j.jaip.2022.10.051 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:152841587 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy